Assessing utility, impact and adoption challenges of AI-enabled prescription advisory tool for type 2 diabetes management: perspectives from endocrinologists in a tertiary hospital (Preprint)

Author:

Yoon SungwonORCID,Goh HendraORCID,Lee Phong ChingORCID,Tan Hong ChangORCID,Teh Ming MingORCID,Lim Dawn Shao TingORCID,Kwee AnnORCID,Suresh ChandranORCID,Carmody DavidORCID,Swee Du SoonORCID,Tan Sarah Ying TseORCID,Wong Andy Jun-WeiORCID,Choo Charlotte Hui-MinORCID,Wee ZongwenORCID,Bee Yong MongORCID

Abstract

BACKGROUND

The clinical management of type 2 diabetes mellitus (T2DM) presents a significant challenge due to the constantly evolving clinical practice guidelines and growing array of drug classes available. Evidence suggests that artificial intelligence (AI)-enabled clinical decision support systems (CDSS) have proven to be effective in assisting clinicians with informed decision-making. Despite the merits of AI-driven CDSS, a significant research gap exists concerning the early-stage implementation and adoption of AI-enabled CDSS in T2DM management.

OBJECTIVE

This study aimed to explore the perspectives of clinicians on the utility and impact of an AI-enabled prescription advisory (APA) tool, developed using a multi-institutions diabetes registry and implemented in specialist endocrinology clinics, and the challenges to its adoption and application.

METHODS

We conducted focus group discussions using a semi-structured interview guide with purposively selected endocrinologists from a tertiary hospital. The focus group discussions were audio recorded and transcribed verbatim. Data were thematically analyzed.

RESULTS

A total of 13 clinicians participated in four focus group discussions. Our findings suggest that the APA tool offered several useful features to assist clinicians in effectively managing T2DM. Specifically, clinicians viewed the AI-generated medication alterations as a good knowledge resource in supporting the clinician's decision-making on drug modifications at the point of care, particularly for patients with co-morbidities. The complication risk prediction was seen as positively impacting patient care by facilitating early doctor-patient communication and initiating prompt clinical responses. However, the interpretability of the risk scores, concerns about over-reliance and automation bias, and issues surrounding accountability and liability hindered the adoption of the APA tool in clinical practice.

CONCLUSIONS

Although the APA tool holds great potential as a valuable resource for improving patient care, further efforts are required to address clinicians' concerns and improve the tool's acceptance and applicability in relevant contexts.

CLINICALTRIAL

N/A

Publisher

JMIR Publications Inc.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3